Fractyl Health Inc
GUTS
Fractyl Health Inc AI Insights
Informational only. Not investment advice.Snapshot
- Cash runway critical: 77.7M cash vs -86.8M FCF TTM implies <12 months runway without new financing[Cash and Equivalents / Free Cash Flow TTM]
- Negative equity (-3.2M) with 62.2M total debt - balance sheet technically insolvent, dependent on future capital raises[Common Stockholders Equity / Total Debt]
- Revenue collapsed 97% YoY to just 3K TTM while burning 78.3M on R&D - pure clinical-stage bet[Total Revenue 1yr Growth TTM]
Watch Triggers
- Cash and Equivalents: Falls below 50M or 6 months runway — Triggers forced financing at distressed terms, severe dilution risk
- Net Common Stock Issuance: New equity raise announced — Signals runway extension but quantifies dilution impact
- Research and Development TTM: Material reduction from 78.3M quarterly run rate — Could indicate pipeline setback or strategic pivot
Bull Case
Recent 78.2M equity raise demonstrates capital market access; 61M working capital provides near-term operational buffer
78.3M R&D spend (80% of OpEx) focused on pipeline - successful clinical readout could transform valuation from 145M market cap
Bear Case
Negative equity (-3.2M) and 62M debt create existential financing risk; any capital raise highly dilutive to 64.7M shares outstanding
97% revenue decline signals no commercial traction; 98.7M annual burn unsustainable without breakthrough clinical data
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage GUTS's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Binary outcome: either successful financing/clinical data or dilution/failure within 12 months
- Sub-12 month cash runway at current burn
- No meaningful revenue to offset expenses
- Recent 78.2M equity raise shows capital access
Public Strategies Rankings
See how Fractyl Health Inc ranks across different investment strategies.
Leverage GUTS's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
GUTS Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$139.65M | — | ||
$124.18M | — | ||
0.00 | — | ||
$3,000 | -96.9% | — | |
$-1.94 | — | ||
-3,291,400% | -3207583.5% | — | |
-4,073,233% | -4008383.8% | — | |
$-86.81M | — | ||
0.00 | — | ||
Beta 5Y (Monthly) | unknown | — |
GUTS Dividend History
GUTS Stock Splits
GUTS SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/12/25 | 09/30/25 | 10-Q | |
08/12/25 | 06/30/25 | 10-Q | |
05/13/25 | 03/31/25 | 10-Q | |
03/03/25 | 12/31/24 | Unknown | |
11/12/24 | 09/30/24 | 10-Q | |
08/14/24 | 06/30/24 | 10-Q | |
05/13/24 | 03/31/24 | 10-Q | |
04/01/24 | 12/31/23 | 10-K | |
02/02/24 | 09/30/23 | 424B4 | |
09/21/23 | 06/30/23 | DRS/A | |
05/13/24 | 03/31/23 | 10-Q | |
02/02/24 | 12/31/22 | 424B4 | |
09/30/22 | 09/30/22 | Unknown | -- |
04/04/22 | 12/31/21 | DRS/A | |
02/03/22 | 09/30/21 | DRS/A | |
06/30/21 | 06/30/21 | DRS | |
02/03/22 | 12/31/20 | DRS/A | |
09/30/20 | 09/30/20 | Unknown | -- |